Bnp Paribas Asset Management Holding S.A. Nevro Corp Transaction History

Bnp Paribas Asset Management Holding S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$22.62 - $39.32 $2.1 Million - $3.65 Million	-92,863 Reduced 47.72%	101,729 $2.59 Million
Q1 2023 May 08, 2023	BUY	$30.17 - $41.11 $72,347 - $98,581	2,398 Added 1.25%	194,592 $7.04 Million
Q4 2022 Feb 09, 2023	SELL	$36.43 - $49.4 $254,754 - $345,454	-6,993 Reduced 3.51%	192,194 $7.61 Million
Q3 2022 Nov 10, 2022	BUY	$40.66 - $53.03 $996,332 - $1.3 Million	24,504 Added 14.03%	199,187 $9.28 Million
Q2 2022 Aug 04, 2022	BUY	$40.85 - $77.67 $425,657 - $809,321	10,420 Added 6.34%	174,683 $7.66 Million
Q1 2022 May 12, 2022	SELL	$59.95 - $92.06 $835,583 - $1.28 Million	-13,938 Reduced 7.82%	164,263 $11.9 Million
Q4 2021 Feb 09, 2022	BUY	$81.07 - $121.29 $301,499 - $451,077	3,719 Added 2.13%	178,201 $14.4 Million
Q3 2021 Nov 08, 2021	SELL	$101.99 - $166.36 $8.36 Million - $13.6 Million	-81,959 Reduced 31.96%	174,482 $20.3 Million
Q2 2021 Aug 05, 2021	BUY	$141.6 - $179.06 $10.1 Million - $12.7 Million	71,024 Added 38.31%	256,441 $42.5 Million
Q1 2021 May 05, 2021	BUY	$132.81 - $182.18 $24.6 Million - $33.8 Million	185,417 New	185,417 $25.9 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.